Related Experiment Video
Updated: Aug 20, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive
Carlota Gudiol1,2,3, Rachel S Hicklen4, Pablo C Okhyusen5
1Infectious Diseases Department, Bellvitge University Hospital, IDIBIELL, University of Barcelona, Barcelona, Spain.
Abstract:
Use of immune checkpoint inhibitors (ICIs), a revolutionary treatment in modern oncology, is frequently complicated by immune-related adverse events (irAEs), which can be confused with infections, and vice versa, thus complicating management decisions. In this study, we review the published cases of infections as simulators of irAEs in cancer patients.
More Related Videos
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Tumor Immunotherapy
Immunodeficiency Diseases
There are three main causes of immunodeficiency...